Point-of-care molecular diagnostics and drug-resistance mechanisms in neglected infectious diseases: current advances and future therapeutic opportunities
Frontiers in Cellular and Infection Microbiology · 26.02.2026 · 16
DOI: 10.3389/fcimb.2026.1769679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 26.02.2026. Verfasst von Qi Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department Clinical Laboratory, The People's Hospital of Danyang, Danyang Hospital Affiliated to Nantong University, Jiangsu, China. Hauptthemen laut MEDLINE: Point-of-Care Systems, Molecular Diagnostic Techniques, Neglected Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rising burden of neglected infectious diseases and the accelerating spread of antimicrobial resistance (AMR) demand rapid, accurate, and decentralized diagnostic solutions. Point-of-care (POC) molecular diagnostics enable early diagnosis and resistance profiling during the clinical encounter, without reliance on centralized laboratories, which is particularly important in low-resource settings. Molecular POC technologies are being developed around the following advances: isothermal nucleic acid amplification technologies, rapid polymerase chain reaction (PCR), CRISPR-based diagnostic detection technologies, nanomaterials-enabled biosensors, and microfluidic platforms for sample-to-results with near laboratory-quality accuracy within clinically relevant timeframes (typically < 30 minutes). The combination of artificial intelligence (AI) and cloud-based digital health systems supports the automated interpretation and provision of real-time surveillance and antimicrobial stewardship. Next-generation molecular POC platforms provide higher sensitivity and mechanistic insights into drug-resistance in TB, malaria, and bacterial infections. Barriers include clinical validation, cost, scalability, and equitable access. The convergence of molecular diagnostics, nanotechnology and AI-powered analytics leads to future-oriented, transformative opportunities in precision therapy areas, AMR surveillance and infectious disease preparedness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department Clinical Laboratory, The People's Hospital of Danyang, Danyang Hospital Affiliated to Nantong University, Jiangsu, China.
- Department Infectious Diseases, The People's Hospital of Danyang, Danyang Hospital Affiliated to Nantong University, Jiangsu, China.
Zitieren
APA
Zhang, Q., Zhang, X., Yang, J., & Li, H. (2026). Point-of-care molecular diagnostics and drug-resistance mechanisms in neglected infectious diseases: current advances and future therapeutic opportunities. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1769679
Vancouver
Zhang Q, Zhang X, Yang J, Li H. Point-of-care molecular diagnostics and drug-resistance mechanisms in neglected infectious diseases: current advances and future therapeutic opportunities. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1769679
BibTeX
@article{Zhang2026,
author = {Zhang, Qi and Zhang, Xiajun and Yang, Jie and Li, Hongliang},
title = {Point-of-care molecular diagnostics and drug-resistance mechanisms in neglected infectious diseases: current advances and future therapeutic opportunities},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1769679}
}
EUVIMED